Ligand · ZD7

ZD7 · 5,7-diethyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-3,4-dihydro-1,6-naphthyridin-2(1H)-one

ZD7, 5,7-diethyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-3,4-dihydro-1,6-naphthyridin-2(1H)-one (C26 H26 N6 O, 438.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…

Component: ZD7
Formula: C26 H26 N6 O
Class: ligand
Structures: 2
PDB entries: 1

Binding sites

ZD7 in 2 structures; the first of them:

4YAY · XFEL structure of human Angiotensin Receptor · ZD7 A1201 · binds ILE31, TYR35, PHE77, TRP84, TYR87, THR88, SER105, VAL108 and 10 more
4YAY · Xfel structure of human angiotensin receptor · ZD7 A1201 · binds ILE31, TYR35, PHE77, TRP84, TYR87, THR88, SER105, VAL108 and 10 more

Residues it binds most

TYR 2, ILE 2, PHE 2, SER 2, ALA 2, ARG 2, CYS 2, LEU 2, PRO 2, THR 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.